Literature DB >> 17254527

Antidepressant use in ambulatory cancer patients.

H Florence Kim1, Michael J Fisch.   

Abstract

Antidepressants are among the most commonly used medications, and they are frequently prescribed for cancer patients. Several dozen antidepressants are available, and they work through at least seven distinct mechanisms. These agents are used primarily to treat depressive and anxiety symptoms and have proven efficacy in treating hot flashes and as adjuvant analgesics. Side effects and drug interactions are frequent with these agents, and proper assessment and monitoring are crucial.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17254527     DOI： 10.1007/s11912-006-0033-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  50 in total

1.  Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides.

Authors:  G Isacsson; P Holmgren; J Ahlner
Journal:  Acta Psychiatr Scand       Date:  2005-04       Impact factor: 6.392

2.  Venlafaxine in neuropathic pain following treatment of breast cancer.

Authors:  Tiina Tasmuth; Brita Härtel; Eija Kalso
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

3.  Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation.

Authors:  Jesús M Prieto; Jorge Atala; Jordi Blanch; Enric Carreras; Montserrat Rovira; Esteve Cirera; Anna Espinal; Cristóbal Gasto
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

Review 4.  SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

Authors:  Stephen M Stahl; Meghan M Grady; Chantal Moret; Mike Briley
Journal:  CNS Spectr       Date:  2005-09       Impact factor: 3.790

5.  Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Authors:  Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

6.  Psychotropic medication use and risk of epithelial ovarian cancer.

Authors:  B L Harlow; D W Cramer; J A Baron; L Titus-Ernstoff; E R Greenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-08       Impact factor: 4.254

Review 7.  Treatment of depression in cancer.

Authors:  Michael Fisch
Journal:  J Natl Cancer Inst Monogr       Date:  2004

8.  Antidepressants and the risk of suicidal behaviors.

Authors:  Hershel Jick; James A Kaye; Susan S Jick
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

9.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

10.  Use of antidepressant medications in relation to the incidence of breast cancer.

Authors:  D Fulton-Kehoe; M A Rossing; C Rutter; M T Mandelson; N S Weiss
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640
View more
  3 in total

1.  Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center.

Authors:  Lincy Subha Lal; Amy Zhuang; Frank Hung; Chun Feng; Rebecca Arbuckle; Michael J Fisch
Journal:  Support Care Cancer       Date:  2011-04-26       Impact factor: 3.603

2.  Cancer pain management-current status.

Authors:  Deepak Thapa; V Rastogi; Vanita Ahuja
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

Review 3.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.